Back to Search
MATE MILAK, M.D.
M.D.
Psychiatry Physician
NPI: 1144346586Individual
Specialties, Licenses & Credentials
Research & Publications (12)
Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.
PMID 19446443·Psychiatry Res·2009
8-other
Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET.
PMID 18344443·J Nucl Med·2008
7-preclinical
The negative syndrome as a dimension: factor analyses of PANSS in major depressive disorder and organic brain disease compared with negative syndrome structures found in the schizophrenia literature.
PMID 17558255·Cogn Behav Neurol·2007
8-other
In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter.
PMID 17180600·Eur J Nucl Med Mol Imaging·2007
7-preclinical
Neuroanatomic correlates of psychopathologic components of major depressive disorder.
PMID 15809407·Arch Gen Psychiatry·2005
4-observational
Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency.
PMID 15607307·Biol Psychiatry·2005
4-observational
Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression.
PMID 19128951·Prostaglandins Leukot Essent Fatty Acids·2009
8-other
Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime alcohol dependence.
PMID 17478085·Eur Neuropsychopharmacol·2007
8-other
Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates.
PMID 17221184·Eur J Nucl Med Mol Imaging·2007
7-preclinical
Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: a novel agonist 5-HT1A receptor PET ligand.
PMID 16458504·Bioorg Med Chem Lett·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1051 RIVERSIDE DR, UNIT 42
NEW YORK, NY 10032 - Phone
- (212) 543-5952
Quick Facts
- NPI
- 1144346586
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 12
Are you this provider?
Claim Your Profile